(Q79775301)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16794364%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Slow-release lanreotide in Graves' ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16794364%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

T-C Chang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16794364%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

S-L Liao

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16794364%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16794364%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16794364%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16794364%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16794364%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

413-422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16794364%20AND%20SRC:MED&resulttype=core&format=json

A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves ophthalmopathy

25 December 2019

cites work

1 reference

12 December 2020

Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study

1 reference

12 December 2020

Measuring disease activity to predict therapeutic outcome in Graves' ophthalmopathy.

1 reference

12 December 2020

Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease

1 reference

12 December 2020

Effects of octreotide treatment on Graves' ophthalmopathy and circulating sICAM-1 levels

1 reference

12 December 2020

Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy

1 reference

12 December 2020

Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach

1 reference

12 December 2020

Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy

1 reference

12 December 2020

[111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity?

1 reference

12 December 2020

Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy.

1 reference

12 December 2020

A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy

1 reference

12 December 2020

Somatostatin analogs: a new tool for the management of Graves' ophthalmopathy

1 reference

12 December 2020

Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease

1 reference

12 December 2020

Somatostatin analogues in the treatment of thyroid eye disease

1 reference

12 December 2020

Classification of Graves' ophthalmopathy

1 reference

12 December 2020

Immunology of Graves' ophthalmopathy

1 reference

12 December 2020

Relationships of orbital computed tomographic findings and activity scores to the prognosis of corticosteroid therapy in patients with Graves' ophthalmopathy.

1 reference

12 December 2020

Role of Octreoscan and Correlation with MR Imaging in Graves' Ophthalmopathy

1 reference

12 December 2020

Somatostatin receptor genes are expressed in lymphocytes from retroorbital tissues in Graves' disease

1 reference

12 December 2020

Classification of eye changes of Graves' disease

1 reference

12 December 2020

Imaging Somatostatin Receptor Activity in Patients with Active Thyroid Eye Disease Using Tc-99m Depreotide

1 reference

12 December 2020

The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy

1 reference

12 December 2020

Modification of the Classification of the Eye Changes of Graves' Disease: Recommendations of the Ad Hoc Committee of The American Thyroid Association

1 reference

12 December 2020

Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy

1 reference

12 December 2020

Therapy of Graves' ophthalmopathy: a novel application of somatostatin analogues

1 reference

12 December 2020

Relationship of eye movement to computed tomographic findings in patients with Graves' ophthalmopathy

1 reference

12 December 2020

Octreotide-scintigraphy is a disease-activity parameter in Graves' ophthalmopathy.

1 reference

12 December 2020

Glycosaminoglycans in thyroid eye disease

1 reference

12 December 2020

Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease

1 reference

12 December 2020

Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment.

1 reference

12 December 2020

Studies on the occurrence of ophthalmopathy in Graves' disease

1 reference

12 December 2020

Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy

1 reference

12 December 2020

The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy

1 reference

12 December 2020

Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease

1 reference

12 December 2020

Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease

1 reference

12 December 2020

Octreotide and Graves' ophthalmopathy and pretibial myxoedema

1 reference

12 December 2020

Somatostatin receptors in the orbits

1 reference

12 December 2020

Lanreotide in the treatment of patients with thyroid eye disease

1 reference

12 December 2020

Pathogenesis of Graves' ophthalmopathy

1 reference

12 December 2020

Effect of octreotide treatment on Graves' ophthalmopathy

1 reference

12 December 2020

Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters

1 reference

12 December 2020

Why the NOSPECS classification of Graves' eye disease should be abandoned, with suggestions for the characterization of this disease

1 reference

12 December 2020